Assessment of Neurosensory Function Following Segmental Mandibular Resection.

NCT03752554 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2019-01-24

No results posted yet for this study

Summary

This study wInclusion criteria for this study will be as follows:

* Age group: from 15 to 60 years old.
* Patients with with non malignant mandibular neoplasms indicated for segmental resection.

Exclusion criteria:

* Patients with malignant mandibular neoplasms.

All cases will undergo surgery under general anesthesia. The mandibular lesion will be segmentally resected. The cuts will be performed with the aid of the prefabricated digital template. The neurovascular bundle will be separated and protected. Then reconstruction will be performed.

Postoperative patient evaluation:

Neurosensory examination:

Assessment of the inferior alveolar nerve function will be performed preoperatively, 2 and 12 weeks postoperatively through Trigeminal somatosensory evoked potential technique. Six months postoperatively by CBCT for assessment of recurrence

Conditions

  • Resection Cavity

Interventions

PROCEDURE

segmental resection

All cases will undergo surgery under general anesthesia. The mandibular lesion will be segmentally resected. The cuts will be performed with the aid of the prefabricated digital template. The neurovascular bundle will be separated and protected. Then reconstruction will be performed

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • ragia mo mounir, professor · kaser elany cairo univeristy

Eligibility

Min Age
15 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-15
Primary Completion
2020-01-01
Completion
2020-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03752554 on ClinicalTrials.gov